Education
About Us
Working with TipRanks
Follow Us
Kirk G. Nielsen Insider Profile
11 Followers
Kirk G. Nielsen, Director at Inari Medical, holds 1.91M shares in CVRx (Ticker: CVRX), holds 61.48K shares in Inari Medical (Ticker: NARI). Most recently, Kirk G. Nielsen Bought ― shares of CVRx on May 19, 2025 for an estimated value of 59.76K.
Profitable Transactions
8 out of 8 Profitable Transactions
Average Return
+70.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kirk G. Nielsen's holdings
Insider Roles
Director
Roles that Kirk G. Nielsen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kirk G. Nielsen
Kirk G. Nielsen's Trading History
Inari Medical
May 30, 2023
―
Uninformative Buy
175.85K
$4.92M
CVRx
May 19, 2025
Director
Informative Buy
59.76K
$15.93M
List of latest transactions for each holding click on a transaction to see Kirk G. Nielsen's performance on stock
You May Also Like
Kirk G. Nielsen insider profile FAQ
What is the percentage of profitable transactions made by Kirk G. Nielsen?
The percentage of profitable transactions made by Kirk G. Nielsen is 100%.
What is the average return per transaction made by Kirk G. Nielsen?
The average return per transaction made by Kirk G. Nielsen is 70.10%.
What stocks does Kirk G. Nielsen hold?
Kirk G. Nielsen holds: NARI, CVRX stocks.
What was Kirk G. Nielsen’s latest transaction?
Kirk G. Nielsen latest transaction was an Informative Buy of $59.76K.
What was Kirk G. Nielsen's most profitable transaction?
Kirk G. Nielsen’s most profitable transaction was an Informative Buy of CVRX stock on May 23, 2022. The return on the trade was 159.60%.
What is Kirk G. Nielsen's role in Inari Medical?
Kirk G. Nielsen's role in Inari Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.